platinum has been researched along with Liver Neoplasms in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (11.11) | 18.7374 |
| 1990's | 5 (9.26) | 18.2507 |
| 2000's | 9 (16.67) | 29.6817 |
| 2010's | 17 (31.48) | 24.3611 |
| 2020's | 17 (31.48) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, MH; Chang, YC; Chen, CL; Chung, YL; Hsiao, M; Li, CH; Lu, CN; Wei, DH | 1 |
| Bian, M; Chen, Y; Fan, R; Liu, W; Lu, Y; Xu, Z; Yang, Z | 1 |
| Chang, CH; Chang, YL; Chen, JS; Hsu, FM; Huang, YL; Lee, JM; Lin, CC; Ma, WL; Yang, JC | 1 |
| An, J; Cao, L; Chen, C; Deng, P; Gu, Q; He, B; Hu, C; Jiang, J; Li, M; Qin, L; Yang, H | 1 |
| Aasi, A; Aasi, E; Mehdi Aghaei, S; Panchapakesan, B | 1 |
| Li, P; Li, S; Li, T; Li, X; Wu, W; Xiao, H; Xie, P; Yang, J; Yu, Y; Zhang, L; Zhang, Y; Zhao, L; Zhao, Z | 1 |
| Chen, J; Chen, P; Pan, Y; Qin, P; Wang, Y; Xiao, X; Zhou, D | 1 |
| Chen, SC; Lai, YH; Tung, KC | 1 |
| Bilewicz, A; Chajduk, E; Majkowska-Pilip, A; Szwed, M; Wawrowicz, K; Żelechowska-Matysiak, K | 1 |
| Adi, A; Anjary, A; Arghirescu, ST; Boc, AG; Boeriu, AI; Boeriu, E; Borda, A; Feciche, B; Horhat, FG; Horhat, ID; Mot, IC; Negrean, RA; Ravulapalli, M; Sabuni, O | 1 |
| Chen, M; Han, H; Lin, X; Lv, T; Qiu, G; Song, Y; Xie, J; Xu, K; Ye, J; Zhan, P | 1 |
| Chen, W; Chen, Y; Feng, X; He, B; Liu, H; Lv, Z; Mao, Z; Sun, W; Tong, R; Wu, J; Yang, B; Yang, H; Yu, G; Yu, H; Zheng, S | 1 |
| Abe, K; Fujita, M; Hayashi, M; Ohira, H; Okai, K; Takahashi, A | 1 |
| Chen, H; Li, C; Li, Z; Liu, H; Ma, W; Meng, X; Xiao, H; Yang, Y; Yu, M; Yu, Y; Yu, Z; Zhang, X | 1 |
| Gao, S; Gou, J; He, H; Tang, X; Wang, Y; Wu, R; Xue, Y; Yin, T; Zhang, Y | 1 |
| Chen, W; He, J; Li, H; Li, X; Liu, C; Qi, M; Sepehrpour, H; Shi, B; Stang, PJ; Sun, Y; Tian, W | 1 |
| Das, N; Kumar Roy, S; Kumar Satija, N; Kumar, A; Raja Gopal, R | 1 |
| Bilewicz, A; Chajduk, E; Gaweł, D; Majkowska-Pilip, A; Pieńkowski, T; Wawrowicz, K | 1 |
| El-Sonbaty, S; Kandil, E; Mahmoud, M; Mansour, S; Medhat, A | 1 |
| Dong, K; Huang, Y; Kang, L; Liu, C; Qu, X; Ren, J; Wang, F; Wang, Z; Zhang, Y | 1 |
| Bosmans, H; Deroose, C; Fieuws, S; Heye, S; Maleux, G; Van Cutsem, E; Verslype, C | 1 |
| Cabrera, T; Roberge, D; Valentine, K | 1 |
| Aoyagi, Y; Igarashi, M; Kamimura, K; Kawai, H; Osaki, A; Suda, T; Takamura, M; Tamura, Y; Tsuchiya, A; Yamagiwa, S | 1 |
| Chen, ZF; Li, YL; Liang, H; Liu, YC; Qin, QP | 1 |
| Chen, X; Jiang, D; Li, Y; Liu, C; Liu, F; Liu, L; Luo, F; Pu, X; Xiang, G; Zhang, L | 1 |
| Du, XJ; Li, HJ; Liu, Y; Shen, S; Sun, CY; Wang, J; Xia, JX; Zhu, YH | 1 |
| Guo, Z; Jiao, Y; Muhammad, N; Wang, K; Wang, X; Zhu, C; Zhu, Z | 1 |
| Bian, ZX; Cheng, GY; Chui, CH; Feng, YH; Gambari, R; Ho, CL; Lam, KH; Lam, PL; Lo, YH; Wang, QW; Wong, RS; Wong, WY | 1 |
| Basso, U; Basterretxea, L; Bielle, J; Del Muro, XG; Guillot, A; Houédé, N; Lainez, N; Locker, G; Lucas, C; Lusuardi, L; Morelli, F; Parra, HS; Spaeth, D; Tambaro, R; Theodore, C; Tonini, G | 1 |
| Du, G; Fu, ZH; Jin, B; Li, J; Meng, XX; Wang, W; Zhang, SZ; Zhou, BH | 1 |
| Dong, K; Dong, R; Zheng, S | 1 |
| Dudeck, O; Gaffke, G; Kraetsch, A; Pech, M; Redlich, U; Ricke, J; Wieners, G | 1 |
| Kang, WK; Lee, J; Lim, HY; Park, JO; Park, SH; Park, YS; Yi, JH; Yim, DS | 1 |
| Couvelard, A; Gillet, A; Goujon, G; Hammel, P; Hentic, O; Lévy, P; Maire, F; Palazzo, M; Rebours, V; Ruszniewski, P; Zappa, M | 1 |
| Huang, Y; Jing, X; Li, X; Li, Y; Meng, F; Xiao, H; Zhou, D | 1 |
| Irie, T; Maeda, M | 1 |
| Hultenby, K; Lagerstedt, AS; Olsson, JM; Thörne, A; von Euler, H | 1 |
| Fujiyama, S; Maeda, S; Noumaru, S; Sato, K; Shibata, J; Tanaka, M; Tomita, K | 1 |
| Böhm, U; Jaehde, U; Junker, A; Kretzschmar, A; Langenbahn, D; Pieck, AC; Tannapfel, A | 1 |
| Au-Yeung, SC; Ho, YP; Li, KK; Pang, SK; Yu, CW | 1 |
| Inubushi, T; Itoh, R; Miyagawa, Y; Morikawa, S; Murata, K; Nitta, N; Ohta, S; Oonaka, Y; Sonoda, A; Takahashi, M; Takamori, M | 1 |
| Jones, WB; Lewis, JL; Schneider, J; Shapiro, F | 1 |
| Gottesman, MM; Hamilton, TC; Johnson, SW; Pastan, I; Shen, D | 1 |
| Bedenne, L; Cercueil, JP; Chauffert, B; Correia, M; Coudert, B; Fargeot, P; Flesch, M; Isambert, N; Krause, D; Osmak, L; Zanetta, S | 1 |
| Kumada, K; Makuuchi, M; Midorikawa, T; Nemoto, H; Sanada, Y; Sasaya, S; Takeuchi, S; Takizawa, K; Uemichi, O; Yamaguchi, M; Yoshizawa, Y | 1 |
| Dehand, J; Jordanov, J | 1 |
| Fujimura, T; Fushida, S; Gabata, T; Kinami, Y; Maeda, M; Nishida, Y; Sakuma, H; Sekino, H; Takeyama, S; Yonemura, Y | 1 |
| Bacchi, M; Bassi, P; Belsanti, V; Bisagni, G; Boni, C; Cocconi, G; Lottici, R; Passalacqua, R; Tonato, M | 1 |
| Abe, R; Akiyoshi, T; Baba, T | 1 |
| Fujiyama, S; Fukushima, S; Kishimoto, S; Nakano, M; Sato, T; Shibata, J | 1 |
| Fujiyama, S; Fukushima, S; Hayashi, Y; Kishimoto, S; Nakano, M; Sato, T; Shibata, J | 1 |
| Asano, M; Ebina, T; Ishigaki, H; Nara, K; Oh-ishi, S; Saitoh, S; Satoh, F; Satoh, S; Satoh, T; Yoshida, Y | 1 |
| Howard, K; Kacew, S; Maroun, JA; Mikhael, NZ; Montpetit, V; Nair, RC; Nanji, A; Stewart, DJ | 1 |
| Mikhael, NZ; Nanji, AA; Stewart, DJ | 1 |
1 review(s) available for platinum and Liver Neoplasms
| Article | Year |
|---|---|
Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
Topics: Adult; Animals; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Lung Neoplasms; Mice; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinases; Platinum; Programmed Cell Death 1 Receptor; Tumor Microenvironment | 2021 |
6 trial(s) available for platinum and Liver Neoplasms
| Article | Year |
|---|---|
Prospective comparison of hydrogel-coated microcoils versus fibered platinum microcoils in the prophylactic embolization of the gastroduodenal artery before yttrium-90 radioembolization.
Topics: Brachytherapy; Catheterization, Peripheral; Coated Materials, Biocompatible; Combined Modality Therapy; Embolization, Therapeutic; Equipment Failure Analysis; Humans; Hydrogels; Liver Neoplasms; Miniaturization; Platinum; Prospective Studies; Prosthesis Design; Radiography; Treatment Outcome; Yttrium Radioisotopes | 2013 |
A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Platinum; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Embolization of the gastroduodenal artery before selective internal radiotherapy: a prospectively randomized trial comparing platinum-fibered microcoils with the Amplatzer Vascular Plug II.
Topics: Aged; Angiography, Digital Subtraction; Arteries; Duodenum; Embolization, Therapeutic; Female; Fluoroscopy; Foreign-Body Migration; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Platinum; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Stomach; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Female; Fluorouracil; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Platinum; Pyrroles; Salvage Therapy; Stomach Neoplasms; Sunitinib; Survival Rate; Taxoids; Tissue Distribution; Treatment Outcome; Young Adult | 2012 |
Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Contrast Media; Dose-Response Relationship, Drug; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Middle Aged; Organoplatinum Compounds; Platinum | 2003 |
Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot study.
Topics: Adult; Aged; Antineoplastic Agents; Balloon Occlusion; Breast Neoplasms; Cell Survival; Cisplatin; Colorectal Neoplasms; Female; Glucose; Hepatic Artery; Humans; Hypotonic Solutions; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Pilot Projects; Platinum; Tumor Cells, Cultured | 2001 |
47 other study(ies) available for platinum and Liver Neoplasms
| Article | Year |
|---|---|
Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatment.
Topics: Animals; Bentonite; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Drug Carriers; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Platinum; Theranostic Nanomedicine | 2021 |
Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Calreticulin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Dendritic Cells; Endoplasmic Reticulum Stress; Humans; Imidazoles; Immunity; Immunogenic Cell Death; Liver Neoplasms; Male; Mice, Inbred C57BL; Platinum; Reactive Oxygen Species; T-Lymphocytes | 2022 |
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Thymoma; Thymus Neoplasms | 2022 |
Anlotinib plus platinum-etoposide as a first-line treatment for extensive-stage small cell lung cancer: A single-arm trial.
Topics: Brain Neoplasms; Etoposide; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Platinum; Quinolines; Small Cell Lung Carcinoma | 2022 |
CNT biodevices for early liver cancer diagnosis based on biomarkers detection- a promising platform.
Topics: Adsorption; Biomarkers, Tumor; Humans; Liver Neoplasms; Nanotubes, Carbon; Platinum | 2022 |
Abplatin
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Humans; Liver Neoplasms; Platinum; Prodrugs | 2022 |
Self-targeting platinum(IV) amphiphilic prodrug nano-assembly as radiosensitizer for synergistic and safe chemoradiotherapy of hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Checkpoint Kinase 1; Chemoradiotherapy; Cisplatin; DNA; Humans; Lactose; Liver Neoplasms; Platinum; Prodrugs; Radiation-Sensitizing Agents; Reactive Oxygen Species | 2022 |
Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report.
Topics: Adenosine Diphosphate Ribose; Adult; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cisplatin; Fanconi Anemia Complementation Group A Protein; Female; Humans; Liver Neoplasms; Male; Mutation; Phthalazines; Piperazines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors | 2022 |
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Metal Nanoparticles; Nanoparticles; Platinum; Reactive Oxygen Species | 2022 |
Insights on Lipomatosis after Platinum-Based Chemotherapy Use in Pediatric Oncology: A Case Report.
Topics: Child; Cisplatin; Humans; Lipoma; Lipomatosis; Liver Neoplasms; Neoplasms, Germ Cell and Embryonal; Platinum | 2022 |
Clinical impact of first-line PD-1 or PD-L1 inhibitors combined with chemotherapy in extensive-stage small cell lung cancer patients: A real-world multicenter propensity score-matched study.
Topics: Etoposide; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Lung Neoplasms; Platinum; Programmed Cell Death 1 Receptor; Propensity Score; Small Cell Lung Carcinoma | 2023 |
Combinatorial photochemotherapy on liver cancer stem cells with organoplatinum(ii) metallacage-based nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Humans; Infrared Rays; Liver; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Metal Nanoparticles; Mice, Nude; Neoplastic Stem Cells; Photochemotherapy; Photosensitizing Agents; Platinum; Porphyrins; Reactive Oxygen Species; Spheroids, Cellular; Xenograft Model Antitumor Assays | 2019 |
Acute kidney injury after platinum-based transcatheter arterial chemoembolization and transarterial infusion chemotherapy in patients with hepatocellular carcinoma.
Topics: Acute Kidney Injury; Aged; Antibiotics, Antineoplastic; Ascites; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Cancer, Regional Perfusion; Diabetes Mellitus; Female; Glomerular Filtration Rate; Humans; Incidence; Liver Neoplasms; Male; Platinum; Prognosis; Retrospective Studies; Risk Factors; Serum Albumin, Human; Survival Rate; Treatment Outcome | 2020 |
Illuminating Platinum Transportation while Maximizing Therapeutic Efficacy by Gold Nanoclusters
Topics: Glutathione; Gold; Humans; Liver Neoplasms; Metal Nanoparticles; Platinum; Theranostic Nanomedicine | 2020 |
β-Cyclodextrin modified Pt(II) metallacycle-based supramolecular hyperbranched polymer assemblies for DOX delivery to liver cancer cells.
Topics: beta-Cyclodextrins; Doxorubicin; Drug Delivery Systems; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Nanostructures; Oxidation-Reduction; Particle Size; Platinum; Polymers; Time Factors | 2020 |
Bare plasmonic metal nanoparticles: synthesis, characterisation and in vitro toxicity assessment on a liver carcinoma cell line.
Topics: Cell Line, Tumor; Gold; Humans; Liver; Liver Neoplasms; Metal Nanoparticles; Platinum; Silver | 2020 |
Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of
Topics: Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Electrons; Female; Gold; Humans; Hydrodynamics; Imaging, Three-Dimensional; Liver Neoplasms; Metal Nanoparticles; Particle Size; Platinum; Polyethylene Glycols; Radioisotopes; Receptor, ErbB-2; Static Electricity; Trastuzumab | 2021 |
Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Matrix Metalloproteinase 9; Metal Nanoparticles; Oxidative Stress; Platinum; Proto-Oncogene Proteins c-bcl-2; Rats; Tumor Suppressor Protein p53 | 2017 |
Nanozyme Decorated Metal-Organic Frameworks for Enhanced Photodynamic Therapy.
Topics: Animals; Carcinoma, Hepatocellular; Catalase; Cell Line, Tumor; Female; HeLa Cells; Humans; Liver Neoplasms; Metal Nanoparticles; Metal-Organic Frameworks; Mice; Neoplasms; Photochemotherapy; Photosensitizing Agents; Platinum; Singlet Oxygen; Tumor Hypoxia | 2018 |
Implanting metal fiducials to guide stereotactic liver radiation: McGill experience and review of current devices, techniques and complications.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fiducial Markers; Gold; Humans; Liver; Liver Neoplasms; Male; Platinum; Radiography; Radiosurgery; Radiotherapy, Image-Guided; Retrospective Studies; Treatment Outcome | 2014 |
A platinum(II) complex of liriodenine from traditional Chinese medicine (TCM): Cell cycle arrest, cell apoptosis induction and telomerase inhibition activity via G-quadruplex DNA stabilization.
Topics: Apoptosis; Aporphines; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Coordination Complexes; G-Quadruplexes; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Platinum; Platinum Compounds; Telomerase | 2014 |
Ultrasensitive strategy based on PtPd nanodendrite/nano-flower-like@GO signal amplification for the detection of long non-coding RNA.
Topics: Biosensing Techniques; Carcinoma, Hepatocellular; Electrochemical Techniques; Graphite; Humans; Limit of Detection; Liver Neoplasms; Nanostructures; Palladium; Platinum; Reproducibility of Results; RNA, Long Noncoding | 2015 |
Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy.
Topics: AC133 Antigen; Animals; Antigens, CD; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Drug Delivery Systems; Glycoproteins; Humans; Liver Neoplasms; Mice, Inbred NOD; Mice, SCID; Micelles; Nanoparticles; Neoplastic Stem Cells; Peptides; Platinum; Receptor, Notch1; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2015 |
Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.
Topics: alpha-Tocopherol; Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Galactosamine; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Platinum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Reactive Oxygen Species | 2016 |
Synthesis of platinum(II) and palladium(II) complexes with 9,9-dihexyl-4,5-diazafluorene and their in vivo antitumour activity against Hep3B xenografted mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Disease Models, Animal; Enzyme Activation; Heterografts; Humans; Liver; Liver Neoplasms; Mice; Organoplatinum Compounds; Palladium; Platinum | 2016 |
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy.
Topics: Aged; Aged, 80 and over; Anemia; Disease Progression; Europe; Female; Humans; Kidney Diseases; Liver Neoplasms; Male; Neoplasm Metastasis; Platinum; Practice Guidelines as Topic; Treatment Failure; Urinary Bladder Neoplasms; Urothelium | 2016 |
Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Self Renewal; Cell Transformation, Neoplastic; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Neoplastic Stem Cells; Platinum; RNA Interference; Wnt Signaling Pathway; Wnt1 Protein | 2016 |
Distinguishing Among Pediatric Hepatoblastomas, Transitional Liver Cell Tumors, and Hepatocellular Carcinomas and Using Appropriate Chemotherapy Regimens.
Topics: Carcinoma, Hepatocellular; Child; Doxorubicin; Hepatoblastoma; Humans; Liver Neoplasms; Platinum | 2017 |
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome | 2012 |
A polymer-(tandem drugs) conjugate for enhanced cancer treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cantharidin; Cell Line, Tumor; Liver Neoplasms; Mice; Nanocapsules; Platinum; Polymers; Treatment Outcome | 2013 |
Placement of 10-millimeter Trufill platinum microcoils in the gastroduodenal artery for intraarterial implantation of a microcatheter-port system to treat liver tumors.
Topics: Arteries; Catheters, Indwelling; Duodenum; Embolization, Therapeutic; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Platinum; Stomach | 2003 |
Animal models for treatment of unresectable liver tumours: a histopathologic and ultra-structural study of cellular toxic changes after electrochemical treatment in rat and dog liver.
Topics: Animals; Dogs; Electric Stimulation Therapy; Electrochemistry; Electrodes; Electrolysis; Female; Histological Techniques; Iridium; Liver; Liver Neoplasms; Microscopy, Electron; Models, Animal; Necrosis; Platinum; Rats | 2003 |
[Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
Topics: Antineoplastic Agents; Colonic Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Platinum | 2004 |
Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
Topics: Antineoplastic Agents; Apoptosis; Cantharidin; Carboplatin; Carcinoma, Hepatocellular; Cell Cycle; Cisplatin; Colorectal Neoplasms; Cyclohexylamines; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Isomerism; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Platinum; Tumor Cells, Cultured | 2006 |
[Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
Topics: Animals; Antineoplastic Agents; Cisplatin; Female; Infusions, Intra-Arterial; Iodized Oil; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Transplantation; Platinum; Rabbits | 2006 |
Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Frontal Lobe; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine | 1996 |
Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines.
Topics: Carcinoma, Hepatocellular; Cisplatin; Cross-Linking Reagents; DNA; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Platinum; Tumor Cells, Cultured | 1996 |
[Tissue platinum distribution and the effect following intra-arterial injection of cisplatin to metastatic liver cancer--a case report].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Platinum; Tissue Distribution | 2001 |
Anti-tumour activity of heavy transition metal complexes against hepatoma cells.
Topics: Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Neoplasms, Experimental; Organometallic Compounds; Palladium; Platinum; Rats; Rhodium; Structure-Activity Relationship; Sulfhydryl Compounds | 1975 |
[Blood kinetics of free-platinum in CDDP hepato-arterial injection therapy].
Topics: Adult; Aged; Cisplatin; Gastrointestinal Neoplasms; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Middle Aged; Platinum | 1991 |
Combination therapy with platinum and etoposide of brain metastases from breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Platinum; Regression Analysis; Remission Induction | 1990 |
Inactivation of cis-diamminedichloroplatinum (II) in blood by sodium thiosulfate.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dogs; Humans; Liver Neoplasms; Platinum; Thiosulfates | 1990 |
Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Cause of Death; Cisplatin; Female; Follow-Up Studies; Hepatic Artery; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Platinum; Suspensions | 1989 |
[Intra-arterial injection of cisplatin suspension in Lipiodol (LPS) in the treatment of hepatocellular carcinoma].
Topics: Animals; Carcinoma, Hepatocellular; Cisplatin; Gastric Mucosa; Humans; Injections, Intra-Arterial; Iodized Oil; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Platinum; Rabbits; Remission Induction; Suspensions; Tissue Distribution | 1989 |
[An autopsy case of rectal cancer receiving cisplatin at total dose of 3.250 mg and platinum concentrations in autopsy tissue samples].
Topics: Adenocarcinoma; Cisplatin; Colon; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Platinum; Rectal Neoplasms; Spleen; Tissue Distribution | 1989 |
Platinum concentrations in human autopsy tumor samples.
Topics: Autopsy; Brain Neoplasms; Cisplatin; Female; Humans; Liver Neoplasms; Male; Neoplasms; Platinum; Spectrophotometry, Atomic | 1988 |
Hypoalbuminemia in patients receiving cisplatin: correlation between liver platinum and decrease in serum albumin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autopsy; Cisplatin; Humans; Liver; Liver Function Tests; Liver Neoplasms; Male; Platinum; Serum Albumin | 1986 |